Low-Cost Strategies Could Prevent Many Projected Deaths Due To Antimicrobial Resistance, OECD Report Says

Forbes: Less Than A Penny A Day Keeps the Superbugs At Bay, Says OECD Report
“Just a couple of dollars a year per person could prevent three quarters of the projected deaths due to so-called superbugs — bacteria that have evolved to resist antibiotics, predicts the Organization for Economic Cooperation and Development (OECD). A new report from the OECD [Wednesday] estimates that antimicrobial resistant infection is on track to kill 30,000 Americans per year by 2050, almost as many as die in motor vehicle accidents. The financial cost to the 33 developed countries included in the study could also be as high as $3.5 billion a year…” (Laursen, 11/7).

Reuters: Just $2 per person a year could halt deadly superbugs, OECD says
“…[The report] proposed a ‘five-pronged assault’ on AMR, including promoting better hygiene, ending over-prescription of antibiotics, rapidly testing patients to ensure they get the right drug for infections, delaying antibiotic prescriptions, and delivering mass media campaigns. The report found some reasons for cautious optimism, with the average growth of drug resistance slowing down across the OECD, but added there were ‘serious causes for concern’…” (Kelland, 11/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.